Walker Luke Nathaniel
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Walker Luke Nathaniel. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ZNTL | Award / Grant | 57,603 | — | — | Jun 17, 2025 | |
| ZNTL | Purchase | 14,200 | $1.76 | $24,992 | Jan 31, 2025 | |
| ZNTL | Award / Grant | 72,481 | — | — | May 24, 2024 | |
| 0001708493 | Chief Medical Officer | Disposition | 135,000 | — | — | Mar 11, 2024 |
| 0001708493 | Chief Medical Officer | Award / Grant | 115,000 | — | — | Jan 7, 2024 |
| 0001708493 | Chief Medical Officer | Award / Grant | 20,000 | — | — | Nov 26, 2023 |
| 0001412067 | SVP, Clinical Development | U | 10,315 | — | — | Mar 9, 2018 |
| 0001412067 | SVP, Clinical Development | Tax Withholding | 637 | $3.92 | $2,497 | Jan 11, 2018 |